Takeda Pharmaceutical
Ramy Riad is an accomplished finance professional with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as SVP CFO & Head of Strategy for Global Plasma-Derived Therapies at Takeda since January 2019, Riad has held pivotal roles in finance leadership at Shire, Abbott, Merck, MSD, and Sanofi over the past two decades. Riad's expertise encompasses market access, strategic pricing, and international finance, with significant contributions made as VP and Head of Finance at Shire and as Global Market Access Director at Abbott. Riad holds an MBA in Finance from Southern New Hampshire University and a Bachelor of Commerce in Accounting/Finance from Cairo University.
This person is not in any teams
This person is not in any offices
Takeda Pharmaceutical
172 followers
For more than 230 years, Takeda has brought hope to people around the world through its people-centered and innovation-driven approach to science and medicine. As a global pharmaceutical leader, Takeda focuses on solving unmet needs where it can make a real difference—and on putting patients first. Its therapeutics focus is oncology, gastroenterology, and the central nervous system, as well as vaccines.